1 The ESC also suggests that pioglitazone should be considered for reducing ASCVD risk in patients with T2D with ASCVD based on the data and net benefit-risk assessment
The sample size was based on a compromise between feasibility, precision, and regulatory considerations 52 , and an estimated 12-month recruitment timeline
doi: 10.1523/JNEUROSCI.2050-12.2012
The suppression of antioxidant proteins, glutathione synthesis enzymes, and NADPH-producing enzymes would lead to ROS accumulation in cancer cells and subsequent oxidative damage to various intracellular components, thus compromising the cell viability
Neuronal activity conveyed through these synapses relays information to OPCs that contributes to determining their proliferation, migration and differentiation, as well as oligodendrocyte survival, and myelination as a whole (Mitew et al., 2018